Industry Trends

Europe Microsurgery Robot Market share was valued at USD 217.1 million in 2020 and is expected to witness 14% CAGR from 2021 to 2027.
 

Get more details on this report - Request Free Sample PDF

Rising R&D funding has led to the development of microsurgery products in the healthcare industry. Research funding will lead to advancements in the products such as reduction in size, advanced features, as well as reduced cost. This will surge the adoption of microsurgery products, boosting the market progression. Similarly, large number of start-ups along with well-established industry participants are involved in R&D activities and are planning to enter the microsurgical robot market in the near future that will stimulate the market demand.

Europe Market, By Application

Based on application, the Europe market is fragmented into neurovascular surgery, ureterorenoscopy, neurovascular surgery, reconstructive surgery, urology surgery, gastrointestinal surgery, obstetrics and gynecology surgery, ENT surgery, micro anastomosis, ophthalmology surgery, oncology surgery, and others. The oncology surgery segment will witness around 15% CAGR over the analysis period. Robotic surgery can be employed for treatment of various types of cancer such as prostate cancer, lung cancer, and colorectal cancer among others. Surging prevalence of cancer across the European countries will augment the demand for microsurgery robot for different surgeries and treatment proving beneficial for the segmental growth.

Europe Market, By End-use

Get more details on this report - Request Free Sample PDF

Europe market, by end-use, is fragmented into research institutes, ambulatory surgical centers, hospitals and clinics as well as others. The research institutes segment was valued more than USD 28 million in 2020 and is anticipated to show lucrative growth over the forthcoming years. Increasing number of research projects and rising need to enhance treatment accuracy will surge the demand for microsurgery robot over the analysis timeframe. Moreover, growing government support and funding in various research processes for the development of advanced products will substantially escalate the segmental growth.    

Europe Market, By Country

Germany microsurgery robot market accounted around 15% market share in 2020 and is estimated to grow at a considerable rate over the analysis period. The growth is attributed to the increasing adoption of advanced technologies in microsurgery robot. Also, increasing preference towards minimally invasive surgeries will spur the microsurgery robot market growth in the country. Rising prevalence of chronic diseases along with increase in geriatric population base in Germany, drives the country growth.

Competitive Market Share

Some of the eminent market players operating in the market are Stryker, Zimmer Biomet, TransEnterix Surgical, Smith & Nephew, Auris Health (Johnson & Johnson), Medtronic, Corindus Inc. (Siemens Healthineers), Medrobotics Corporation and Intuitive Surgical. The industry applicants are undertaking various market strategies such as product approval and innovations to expand their customer base and to cater the rising demand. In January 2019, Zimmer Biomet received FDA 510 (k) clearance for its Rosa system. This system is used for total knee replacement surgeries. This strategy helped the company to strengthen its position in the microsurgery robot market.

Industry Background

The use of robotics in surgery was postulated in 1967. The notion of robotics used for surgery began beyond 50 years before, however actual use of surgical robot commenced in the late 1980s with Robodoc, the orthopaedic image-guided system developed by Hap Paul and William Bargar, for use in replacement of prosthetic hip. Presently, the most widely available multipurpose robotic surgery system is the Intuitive Surgical Inc.'s da Vinci Surgical System. This system is extensively used in operating rooms across several countries of Europe.